About Eclipsebio
RNA biology expertise for drug development and research
Eclipsebio was founded in 2017 in San Diego by RNA biologists and drug developers. We combine AI-powered sequence design, rapid prototyping, and sequencing-based analytics through our integrated eCOMPASS platform, and provide proprietary analytical technologies as individual capabilities for programs that need targeted support. Over 300 partners across pharma, biotech, and academia, including 80% of the top biopharma companies by revenue, trust our team to deliver insights they can act on.
RNA biology expertise, applied
Our proprietary next-generation sequencing assays and AI models provide actionable insights unavailable from any other provider. We support drug developers and researchers with data-driven tools for confident decision-making, backed by 30+ peer-reviewed publications and trusted by 300+ partners, including 80% of the top biopharma companies.
AI-powered RNA design built by RNA biologists, backed by 1M+ proprietary RNA data points
Sequencing-based analytics at nucleotide resolution for comprehensive characterization
Integrated design-make-characterize workflow for optimized, characterized candidates
Learn more
about Eclipsebio
Meet our leadership team
Our team of RNA experts brings deep experience in drug development and RNA biology. Learn more about our leadership and advisory board.
Latest news
Our team presents at conferences and webinars on RNA solutions and partnership opportunities. See where we will be next.
Explore our events
Our team of RNA experts is frequently presenting about our cutting-edge solutions at conferences and webinars. Discover where we will be next.
Join our team
Are you passionate about the power of RNA-based therapeutics to treat previously untreatable diseases? Join our team today to help our partners succeed in creating the next generation of RNA medicines.